INDIANAPOLIS--(BUSINESS WIRE)--Gate Neurosciences, a clinical-stage biotechnology company using precision medicine to develop next-generation neuroscience therapies, today announced upcoming ...
LA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe ...